FTSE 100: Index falls as earnings results weigh; pound below $1.33, Bodycote soars
Investing.com - Pulmatrix reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Pulmatrix announced earnings per share of $-1.4500 on revenue of $1.87M. Analysts polled by Investing.com EPS of $-1.5100 on revenue of $1.16M.
Pulmatrix 's are down 16.92% and is trading at $3.6020 , still down 79.06% from its 52 week high of $17.20 set on Wednesday, November 10, 2021.
Pulmatrix shares gained 2.04% to trade at $3.6020 in intra-day trade the report.
Pulmatrix follows other major Healthcare sector earnings this month
Pulmatrix's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar